A private placement of ordinary shares brought Oxford Nanopore Technologies $50.8 million in new funding. Oxford will use the money to create a commercial infrastructure, increase its production capabilities, add to is intellectual property portfolio and support research and development. The firm intends to commercialize two DNA sequencing platforms this year.
Gene sequencing device maker pulls in $50.8M in financing
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||